APA 6th Edition MATKOVIĆ, Z., PISKAČ, N., LJUBIČIĆ, Đ. i TUDORIĆ, N. (2010). LIJEČENJE EGZACERBACIJA ASTME U ODRASLIH. Liječnički vjesnik, 132 (5-6), 168-173. Preuzeto s https://hrcak.srce.hr/63581
MLA 8th Edition MATKOVIĆ, ZINKA, et al. "LIJEČENJE EGZACERBACIJA ASTME U ODRASLIH." Liječnički vjesnik, vol. 132, br. 5-6, 2010, str. 168-173. https://hrcak.srce.hr/63581. Citirano 12.12.2019.
Chicago 17th Edition MATKOVIĆ, ZINKA, NEVENKA PISKAČ, ĐIVO LJUBIČIĆ i NEVEN TUDORIĆ. "LIJEČENJE EGZACERBACIJA ASTME U ODRASLIH." Liječnički vjesnik 132, br. 5-6 (2010): 168-173. https://hrcak.srce.hr/63581
Harvard MATKOVIĆ, Z., et al. (2010). 'LIJEČENJE EGZACERBACIJA ASTME U ODRASLIH', Liječnički vjesnik, 132(5-6), str. 168-173. Preuzeto s: https://hrcak.srce.hr/63581 (Datum pristupa: 12.12.2019.)
Vancouver MATKOVIĆ Z, PISKAČ N, LJUBIČIĆ Đ, TUDORIĆ N. LIJEČENJE EGZACERBACIJA ASTME U ODRASLIH. Liječnički vjesnik [Internet]. 2010 [pristupljeno 12.12.2019.];132(5-6):168-173. Dostupno na: https://hrcak.srce.hr/63581
IEEE Z. MATKOVIĆ, N. PISKAČ, Đ. LJUBIČIĆ i N. TUDORIĆ, "LIJEČENJE EGZACERBACIJA ASTME U ODRASLIH", Liječnički vjesnik, vol.132, br. 5-6, str. 168-173, 2010. [Online]. Dostupno na: https://hrcak.srce.hr/63581. [Citirano: 12.12.2019.]
Sažetak Asthma exacerbation is characterized by a rapid and progressive worsening of symptoms, mainly dyspnea, cough, wheezing and chest tightness. The intensity of an exacerbation may vary form a mild, transient worsening marked by a cough and moderate shortness of breath to a very severe and life-threatening condition. The clinical features of asthma include increased rate of breathing, cough, and prolonged and difficult expiration. The expiratory flow limitation could be quantified, objectified, and monitored by the lung function measurements (PEF or FEV1). It is of crucial importance to recognize properly the early signs of an exacerbation, judge its severity, and promptly start the treatments. The strategy of the treatment of an asthma exacerbation includes the repeated administration of rapid-acting inhaled bronchodilators, the early introduction of systemic glucocorticoids and oxygen supplementation. The treatment is aimed to resolve the airflow limitation and ameliorate the hypoxemia, as quickly as possible. Mild exacerbations could be treated in general practice while the severe ones should be treated in emergence units.